EDT Cathie Wood’s ARK Investment bought 94K shares of Tempus AI (TEM) todayOptimize Your Investment Research with SparkEffectively assess ...

EDT Cathie Wood’s ARK Investment bought 162K shares of Teradyne (TER) todayOptimize Your Investment Research with SparkEffectively assess ...

Cathie Wood foresees 7.3% GDP growth, while claiming the biggest productivity gains in history lie just ahead.

In 2022, he and Schroeder founded Druid Ventures, a Web3 and blockchain-focused investment fund. The relationship with Wood’s team at Ark dates back to when the firm moved to St. Petersburg in ...

So we expect to probably be in the mid-70s later this year." Cathie Wood, CEO and chief investment officer of ARK Invest, speaks during the Bitcoin 2022 Conference at the Miami Beach Convention ...

Cathie Wood, head of Ark Investment Management, frequently adjusts her positions, adding to a holding when the stock falls and selling when it rises. She seems to have done that in February with a ...

Cathie Wood’s Ark Invest made a significant move on Tuesday, selling more than 550,000 shares of UiPath (NYSE:PATH) as the company’s stock continues to decline. The global software provider ...

Cathie Wood’s ARK ETFs have made a series of trades on Monday, March 3rd, 2025, with significant moves in various sectors. The investment management firm, known for its focus on disruptive ...

Cathie Wood has called the current market as “the last leg of a rolling recession,” and would witness deflationary boom in Q2 ...

These investments highlight ARK's interest in companies that are innovating within their respective fields of mobile savings and digital operations management. Investors following Cathie Wood's ...

On Friday, Cathie Wood-led Ark Invest made significant trades involving stocks such as Iridium Communications Inc IRDM, Twist Bioscience Corp TWST, PagerDuty Inc PD, Beam Therapeutics Inc BEAM ...

The IBTA, PSNL, ABSI, and RXRX Trades On the buying side, Ark Invest added shares of Ibotta Inc, Personalis Inc, Absci Corp, and Recursion Pharmaceuticals Inc to its ARKF and ARKG funds.